Skip to content
Screener

Absci Corporation ABSI Total Operating Expenses

Total Operating Expenses at other companies

Schrodinger logo
SchrodingerSDGR
$73.98M-6.4%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$45.64M-14.8%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$66.83M+0.2%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$60.19M+8.8%
Assembly Biosciences logo
Assembly BiosciencesASMB
$19.58M+1.2%
Xencor logo
XencorXNCR
$88.29M+15.0%

Segments

By segment

See full
Segment One$31.06M+7.4%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.41B+235%
Enterprise value$1.4B+279%
P/S765.8×+664×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Absci Corporation’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:24 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001672688-26-000088
(In thousands, except for share and per share data)For the Three Months Ended March 31, 20262025
Research and development19,27516,364
Selling, general and administrative9,0589,472
Depreciation and amortization2,7283,072
Total operating expenses31,06128,908
Operating loss(30,846)(27,729)
Other income (expense)
Interest expense(18)(79)
Other income, net1,2831,458

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Absci Corporation's total operating expenses?
Absci Corporation (ABSI) reported total operating expenses of $31.06M in Q1 2026.
How has Absci Corporation's total operating expenses changed year-over-year?
Absci Corporation's total operating expenses increased by 7.4% year-over-year, from $28.91M to $31.06M.
What is the long-term trend for Absci Corporation's total operating expenses?
Over 4 years (2021 to 2025), Absci Corporation's total operating expenses has grown at a 11.4% compound annual growth rate (CAGR), from $80.02M to $123.12M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

Ask your AI about Absci Corporation's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude